Roger L. White

2.9k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Roger L. White is a scholar working on Pharmacology, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Roger L. White has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 21 papers in Molecular Medicine and 12 papers in Applied Microbiology and Biotechnology. Recurrent topics in Roger L. White's work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (21 papers) and Antibiotic Use and Resistance (12 papers). Roger L. White is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (21 papers) and Antibiotic Use and Resistance (12 papers). Roger L. White collaborates with scholars based in United States, Japan and Türkiye. Roger L. White's co-authors include Lawrence V. Friedrich, John A. Bosso, David S. Burgess, Gregory E. Steinkraus, Charles R. Bonapace, Lawrence L. Michaelis, Carolyn J. Wilkinson, John H. Sanders, Arthur J. Roberts and Peter R. Lichtenthal and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and Journal of Clinical Microbiology.

In The Last Decade

Roger L. White

52 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test

1996 572 citations Roger L. White, David S. Burgess et al. profile →

Peers

Roger L. White

PHARM

EPIDE

D. S. Reeves United Kingdom

Andrea Novelli Italy

Thomas Gottlieb Australia

C H Nightingale United States

Karen E. Bowker United Kingdom

R. Williamson France

Richard Bax United Kingdom

Véronique Dubois France

Laurent Massias France

Barry Hafkin United States

D. S. Reeves United Kingdom

Roger L. White

680 ×1.1

PHARM

480 ×0.8

328 ×0.6

438 ×1.1

EPIDE

211 ×0.5

Citations per year, relative to Roger L. White Roger L. White (= 1×) peers D. S. Reeves

Countries citing papers authored by Roger L. White

Since Specialization

Citations

This map shows the geographic impact of Roger L. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. White more than expected).

Fields of papers citing papers by Roger L. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. White. The network helps show where Roger L. White may publish in the future.

Co-authorship network of co-authors of Roger L. White

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. White. A scholar is included among the top collaborators of Roger L. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. White. Roger L. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alawieh, Ali, et al.. (2015). A computational model to monitor and predict trends in bacterial resistance. Journal of Global Antimicrobial Resistance. 3(3). 174–183. 6 indexed citations

Drew, Richard H., Roger L. White, Conan MacDougall, Elizabeth D. Hermsen, & Robert C. Owens. (2009). Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(5). 593–607. 62 indexed citations

Bosso, John A., et al.. (2003). A Novel Method of Estimating Cost of Therapy by Using Patient Population Characteristics: Analysis of Fluoroquinolones in Various Populations with Different Distributions of Renal Function. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(7). 925–932. 1 indexed citations

Bonapace, Charles R., Roger L. White, Lawrence V. Friedrich, & John A. Bosso. (2002). Differences in Antimicrobial Drug Exposure in Patients with Various Degrees of Renal Function Based on Recommendations from Dosing References. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1097–1104. 5 indexed citations

Bonapace, Charles R., John A. Bosso, Lawrence V. Friedrich, & Roger L. White. (2002). Comparison of methods of interpretation of checkerboard synergy testing. Diagnostic Microbiology and Infectious Disease. 44(4). 363–366. 152 indexed citations

White, Roger L., et al.. (2001). Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. Diagnostic Microbiology and Infectious Disease. 39(1). 39–47. 10 indexed citations

White, Roger L.. (2001). What In Vitro Models of Infection Can and Cannot Do. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(11P2). 292S–301S. 23 indexed citations

White, Roger L., et al.. (2001). Effect of removal of duplicate isolates on cumulative susceptibility reports. Diagnostic Microbiology and Infectious Disease. 39(4). 251–256. 23 indexed citations

Bonapace, Charles R., Roger L. White, Lawrence V. Friedrich, & John A. Bosso. (2000). Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagnostic Microbiology and Infectious Disease. 38(1). 43–50. 110 indexed citations

10.

White, Roger L., et al.. (2000). Assessment of the Relationship between Antimicrobial Usage and Susceptibility: Differences between the Hospital and Specific Patient-Care Areas. Clinical Infectious Diseases. 31(1). 16–23. 54 indexed citations

11.

Friedrich, Lawrence V., Roger L. White, & John A. Bosso. (1999). Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram‐Negative Aerobes. Clinical Infectious Diseases. 28(5). 1017–1024. 48 indexed citations

12.

Bosso, John A., Charles R. Bonapace, Patrick A. Flume, & Roger L. White. (1999). A Pilot Study of the Efficacy of Constant‐Infusion Ceftazidime in the Treatment of Endobronchial Infections in Adults with Cystic Fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(5). 620–626. 23 indexed citations

13.

White, Roger L.. (1998). Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update. Asian Cardiovascular and Thoracic Annals. 6(1). 3–10. 1 indexed citations

14.

Berg, Paul H., Eberhard O. Voit, & Roger L. White. (1996). A pharmacodynamic model for the action of the antibiotic imipenem onPseudomonas aeruginosa populationsin vitro. Bulletin of Mathematical Biology. 58(5). 923–938. 12 indexed citations

15.

White, Roger L., et al.. (1994). The Costs of Burn Care: An Analysis With an Emphasis on the Use of Parenteral Antimicrobials. Journal of Burn Care & Rehabilitation. 15(3). 244–250. 12 indexed citations

16.

Kays, Meg, Roger L. White, Lawrence V. Friedrich, & Victor E. Del Bene. (1992). Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.. PubMed. 13(5). 596–605. 7 indexed citations

17.

White, Roger L., et al.. (1991). Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. Journal of Clinical Microbiology. 29(2). 398–400. 33 indexed citations

18.

Friedrich, Lawrence V., et al.. (1990). The Effect of Tourniquet Inflation on Cefazolin Tissue Penetration During Total Knee Arthroplasty. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(6). 373–377. 12 indexed citations

19.

Friedrich, Lawrence V., et al.. (1990). Pharmacokinetic evaluation of aztreonam in burn patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 241. 4 indexed citations

20.

Roberts, Arthur J., Stewart Spies, John H. Sanders, et al.. (1981). Serial assessment of left ventricular performance following coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 81(1). 69–84. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact